Ryan Cross the Science Boss
@rlcscienceboss
Senior Science Correspondent for @Endpts covering biotech, drug discovery, gene editing, RNA, and more. Formerly at Boston Globe and C&EN. Signal: RyanCross.25
ID: 3056932372
23-02-2015 19:27:42
2,2K Tweet
4,4K Takipçi
833 Takip Edilen
In another interesting alternative to animal models, the organoid startup Parallel Bio has raised $21 million to test drugs and vaccines in its lymph node-in-a-dish technology, sourced from 100 human tissue donors. Read more in my exclusive for Endpoints News - endpoints.news/organoid-start…